Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 19,000 | 59,000 | 61,000 | 50,000 | 45,000 | -- |
| Gross Profit | -19,000 | -59,000 | -61,000 | -50,000 | -45,000 | -- |
| Selling General And Administration | 8.8M | 2.2M | 1.2M | 3.5M | 745,000 | -- |
| General And Administrative Expense | 8.8M | 2.2M | 1.2M | 3.5M | 745,000 | -- |
| Other Operating Expenses | 1.0M | 2.2M | 1.3M | 1.7M | 816,000 | -- |
| Operating Expense | 10.0M | 4.8M | 2.4M | 6.0M | 3.9M | -- |
| Operating Income | -10.1M | -4.9M | -2.5M | -6.1M | -3.9M | -- |
| EBIT | -10.1M | -4.9M | -2.5M | -6.1M | -3.9M | -- |
| Interest Income | 360,000 | 385,000 | 158,000 | 386,000 | 185,000 | -- |
| Interest Income Non Operating | 360,000 | 385,000 | 158,000 | 386,000 | 185,000 | -- |
| Net Interest Income | 360,000 | 385,000 | 158,000 | 386,000 | 185,000 | -- |
| Other Income Expense | -991,000 | 566,000 | 98,000 | -719,000 | 409,000 | -- |
| Other Non Operating Income Expenses | 51,000 | 50,000 | 75,000 | 44,000 | 111,000 | -- |
| Gain On Sale Of Security | -1.0M | 516,000 | 23,000 | -763,000 | 298,000 | -- |
| Pretax Income | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Income From Continuing Operation Net Minority Interest | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Income Including Noncontrolling Interests | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Income Common Stockholders | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Income | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| EBITDA | -10.0M | -4.8M | -2.4M | -6.0M | -3.9M | -- |
| Normalized EBITDA | -9.0M | -5.3M | -2.5M | -5.2M | -4.2M | -- |
| Reconciled Depreciation | 22,000 | 59,000 | 61,000 | 50,000 | 45,000 | -- |
| Basic EPS | -0.09 | -0.04 | -0.02 | -- | -0.03 | -0.01 |
| Diluted EPS | -0.09 | -0.04 | -0.02 | -- | -0.03 | -0.01 |
| Basic Average Shares | 118.5M | 106.5M | 105.6M | -- | 101.0M | 94.3M |
| Diluted Average Shares | 118.5M | 106.5M | 105.6M | -- | 101.0M | 94.3M |
| Total Unusual Items | -1.0M | 516,000 | 23,000 | -763,000 | 298,000 | -- |
| Total Unusual Items Excluding Goodwill | -1.0M | 516,000 | 23,000 | -763,000 | 298,000 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -9.7M | -4.4M | -2.3M | -5.6M | -3.6M | -- |
| Diluted NI Availto Com Stockholders | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Income Continuous Operations | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Non Operating Interest Income Expense | 360,000 | 385,000 | 158,000 | 386,000 | 185,000 | -- |
| Other Gand A | 144,000 | 234,000 | 196,000 | 231,000 | 139,000 | -- |
| Provision For Doubtful Accounts | 189,000 | 364,000 | -- | 761,000 | 2.3M | 0.00 |
| Reconciled Cost Of Revenue | 19,000 | 59,000 | 61,000 | 50,000 | 45,000 | -- |
| Salaries And Wages | 8.7M | 2.0M | 994,000 | 3.3M | 606,000 | -- |
| Total Expenses | 10.1M | 4.9M | 2.5M | 6.1M | 3.9M | -- |
| Total Operating Income As Reported | -9.9M | -4.5M | -2.5M | -5.3M | -1.6M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 78.7M | 24.3M | 14.4M | 22.6M | 28.3M | -- |
| Cash Cash Equivalents And Short Term Investments | 78.7M | 24.3M | 14.4M | 22.6M | 28.3M | -- |
| Cash Financial | 78.7M | 24.3M | 14.4M | 22.6M | 28.3M | -- |
| Accounts Receivable | 0.00 | 2.3M | 2.3M | 2.3M | 2.6M | -- |
| Receivables | 0.00 | 2.3M | 2.3M | 2.3M | 2.6M | -- |
| Prepaid Assets | 548,000 | 688,000 | 546,000 | 512,000 | -- | -- |
| Current Assets | 79.2M | 27.3M | 17.3M | 25.5M | 30.9M | -- |
| Net PPE | 102.4M | 94.8M | 90.3M | 84.5M | 79.8M | -- |
| Total Non Current Assets | 107.0M | 97.2M | 92.7M | 86.9M | 82.9M | -- |
| Total Assets | 186.3M | 124.5M | 110.0M | 112.4M | 113.8M | -- |
| Current Debt And Capital Lease Obligation | 4,000 | 4,000 | 25,000 | 45,000 | 65,000 | -- |
| Accounts Payable | -- | -- | -- | 1.6M | -- | 988,000 |
| Payables | -- | -- | -- | 1.6M | -- | 988,000 |
| Payables And Accrued Expenses | 3.9M | 1.7M | 2.0M | 2.8M | 854,000 | -- |
| Current Accrued Expenses | -- | -- | -- | 1.2M | -- | 476,000 |
| Current Liabilities | 3.9M | 1.7M | 2.0M | 2.8M | 919,000 | -- |
| Long Term Capital Lease Obligation | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 3.9M | 1.7M | 2.0M | 2.8M | 919,000 | -- |
| Common Stock | 313.3M | 248.8M | 231.3M | 230.9M | 231.0M | -- |
| Capital Stock | 313.3M | 248.8M | 231.3M | 230.9M | 231.0M | -- |
| Additional Paid In Capital | 45.6M | 40.0M | 38.6M | 38.3M | 35.6M | -- |
| Retained Earnings | -176.9M | -166.2M | -162.3M | -160.1M | -153.7M | -- |
| Gains Losses Not Affecting Retained Earnings | 360,000 | 254,000 | 420,000 | 418,000 | 20,000 | -- |
| Other Equity Adjustments | 360,000 | 254,000 | 420,000 | 418,000 | 20,000 | -- |
| Common Stock Equity | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Stockholders Equity | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Total Equity Gross Minority Interest | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Total Capitalization | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Net Tangible Assets | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Tangible Book Value | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Working Capital | 75.3M | 25.6M | 15.2M | 22.7M | 30.0M | -- |
| Invested Capital | 182.4M | 122.8M | 108.0M | 109.6M | 112.9M | -- |
| Total Debt | 4,000 | 4,000 | 25,000 | 45,000 | 65,000 | -- |
| Share Issued | 118.5M | 106.5M | 101.2M | 101.0M | 101.0M | -- |
| Ordinary Shares Number | 118.5M | 106.5M | 101.2M | 101.0M | 101.0M | -- |
| Capital Lease Obligations | 4,000 | 4,000 | 25,000 | 45,000 | 65,000 | -- |
| Current Capital Lease Obligation | 4,000 | 4,000 | 25,000 | 45,000 | 65,000 | -- |
| Non Current Accounts Receivable | 4.6M | 2.4M | 2.5M | 2.4M | 3.1M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.1M | -3.0M | -2.5M | -1.3M | -2.2M | -- |
| Cash Flow From Continuing Operating Activities | -1.1M | -3.0M | -2.5M | -1.3M | -2.2M | -- |
| Depreciation And Amortization | 22,000 | 59,000 | 61,000 | 50,000 | 45,000 | -- |
| Depreciation Amortization Depletion | 22,000 | 59,000 | 61,000 | 50,000 | 45,000 | -- |
| Stock Based Compensation | 8.3M | 1.5M | 639,000 | 2.7M | 291,000 | -- |
| Change In Working Capital | 652,000 | -36,000 | -823,000 | -1.3M | 1.1M | -- |
| Change In Receivables | 140,000 | -114,000 | -61,000 | -2.7M | 1.9M | -- |
| Change In Payables And Accrued Expense | 512,000 | 78,000 | -762,000 | 1.4M | -820,000 | -- |
| Other Non Cash Items | -136,000 | -- | -- | -- | -- | -- |
| Capital Expenditure | -7.2M | -5.0M | -5.9M | -4.2M | -3.5M | -- |
| Purchase Of PPE | -1.2M | -- | -- | -459,000 | 8,000 | -- |
| Net PPE Purchase And Sale | -1.2M | -13,000 | -12,000 | -459,000 | 8,000 | -- |
| Investing Cash Flow | -7.6M | -5.0M | -5.9M | -4.2M | -3.5M | -- |
| Cash Flow From Continuing Investing Activities | -7.2M | -5.0M | -5.9M | -4.2M | -3.5M | -- |
| Repayment Of Debt | 0.00 | -21,000 | -20,000 | -20,000 | -16,000 | -- |
| Net Issuance Payments Of Debt | 0.00 | -21,000 | -20,000 | -20,000 | -16,000 | -- |
| Issuance Of Capital Stock | 63.5M | -- | -- | -55,000 | 21.2M | -- |
| Net Common Stock Issuance | 63.5M | -- | -- | -55,000 | 21.2M | -- |
| Financing Cash Flow | 63.5M | 17.4M | -20,000 | -75,000 | 21.2M | -- |
| Cash Flow From Continuing Financing Activities | 63.5M | 17.4M | -20,000 | -75,000 | 21.2M | -- |
| Effect Of Exchange Rate Changes | -513,000 | 566,000 | 112,000 | -49,000 | 200,000 | -- |
| Changes In Cash | 54.9M | 9.4M | -8.4M | -5.6M | 15.5M | -- |
| Beginning Cash Position | 24.3M | 14.4M | 22.6M | 28.3M | 12.6M | -- |
| End Cash Position | 78.7M | 24.3M | 14.4M | 22.6M | 28.3M | -- |
| Free Cash Flow | -8.3M | -8.1M | -8.3M | -5.5M | -5.7M | -- |
| Capital Expenditure Reported | -6.1M | -5.0M | -5.8M | -3.7M | -3.5M | -- |
| Common Stock Issuance | 63.5M | -- | -- | -55,000 | 21.2M | -- |
| Long Term Debt Payments | 0.00 | -21,000 | -20,000 | -20,000 | -16,000 | -- |
| Net Foreign Currency Exchange Gain Loss | 620,000 | -732,000 | -110,000 | 448,000 | -271,000 | -- |
| Net Income From Continuing Operations | -10.7M | -3.9M | -2.2M | -6.4M | -3.3M | -- |
| Net Long Term Debt Issuance | 0.00 | -21,000 | -20,000 | -20,000 | -16,000 | -- |
| Operating Gains Losses | 620,000 | -732,000 | -110,000 | 448,000 | -271,000 | -- |
| Provisionand Write Offof Assets | 189,000 | -- | -- | -- | 0.00 | -- |